Patents Assigned to Serimmune Inc.
  • Patent number: 11828762
    Abstract: The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: November 28, 2023
    Assignee: Serimmune Inc.
    Inventors: Patrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert
  • Patent number: 10871494
    Abstract: The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: December 22, 2020
    Assignee: SERIMMUNE INC.
    Inventors: Patrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert
  • Patent number: 10386373
    Abstract: The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: August 20, 2019
    Assignee: Serimmune Inc.
    Inventors: Patrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert